Literature DB >> 22921969

Outcomes of pulmonary valve replacement in 170 patients with chronic pulmonary regurgitation after relief of right ventricular outflow tract obstruction: implications for optimal timing of pulmonary valve replacement.

Cheul Lee1, Yang Min Kim, Chang-Ha Lee, Jae Gun Kwak, Chun Soo Park, Jin Young Song, Woo-Sup Shim, Eun Young Choi, Sang Yun Lee, Jae Suk Baek.   

Abstract

OBJECTIVES: The objectives of this study were to evaluate outcomes of pulmonary valve replacement (PVR) in patients with chronic pulmonary regurgitation (PR) and to better define the optimal timing of PVR.
BACKGROUND: Although PVR is effective in reducing right ventricular (RV) volume overload in patients with chronic PR, the optimal timing of PVR is not well defined.
METHODS: A total of 170 patients who underwent PVR between January 1998 and March 2011 for chronic PR were retrospectively analyzed. To define the optimal timing of PVR, pre-operative and post-operative cardiac magnetic resonance imaging (MRI) data (n = 67) were analyzed.
RESULTS: The median age at the time of PVR was 16.7 years. Follow-up completeness was 95%, and the median follow-up duration was 5.9 years. Overall and event-free survival at 10 years was 98% and 70%, respectively. Post-operative MRI showed significant reduction in RV volumes and significant improvement in biventricular function. Receiver-operating characteristic curve analysis revealed a cutoff value of 168 ml/m(2) for non-normalization of RV end-diastolic volume index (EDVI) and 80 ml/m(2) for RV end-systolic volume index (ESVI). Cutoff values for optimal outcome (normalized RV volumes and function) were 163 ml/m(2) for RV EDVI and 80 ml/m(2) for RV ESVI. Higher pre-operative RV ESVI was identified as a sole independent risk factor for suboptimal outcome.
CONCLUSIONS: Midterm outcomes of PVR in patients with chronic PR were acceptable. PVR should be considered before RV EDVI exceeds 163 ml/m(2) or RV ESVI exceeds 80 ml/m(2), with more attention to RV ESVI.
Copyright © 2012 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22921969     DOI: 10.1016/j.jacc.2012.03.077

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  53 in total

1.  4-D flow magnetic-resonance-imaging-derived energetic biomarkers are abnormal in children with repaired tetralogy of Fallot and associated with disease severity.

Authors:  Joshua D Robinson; Michael J Rose; Maria Joh; Kelly Jarvis; Susanne Schnell; Alex J Barker; Cynthia K Rigsby; Michael Markl
Journal:  Pediatr Radiol       Date:  2018-12-01

2.  Clinical issues and outcomes in adults following repair of tetralogy of fallot.

Authors:  Bejal Pandya; Michael A Quail; Seamus Cullen
Journal:  Curr Treat Options Cardiovasc Med       Date:  2013-10

3.  Pressure overloaded right ventricles: a multicenter study on the importance of trabeculae in RV function measured by CMR.

Authors:  Mieke M P Driessen; Vivan J M Baggen; Hendrik G Freling; Petronella G Pieper; Arie P van Dijk; Pieter A Doevendans; Repke J Snijder; Marco C Post; Folkert J Meijboom; Gertjan T Sieswerda; Tim Leiner; Tineke P Willems
Journal:  Int J Cardiovasc Imaging       Date:  2014-01-20       Impact factor: 2.357

4.  Comparison of valvar and right ventricular function following transcatheter and surgical pulmonary valve replacement.

Authors:  Wendy F Li; Heidi Pollard; Mohsen Karimi; Jeremy D Asnes; William E Hellenbrand; Veronika Shabanova; Constance G Weismann
Journal:  Congenit Heart Dis       Date:  2017-11-17       Impact factor: 2.007

5.  National Trends in Hospitalizations of Adults With Tetralogy of Fallot.

Authors:  Ada C Stefanescu Schmidt; Doreen DeFaria Yeh; Sara Tabtabai; Kevin F Kennedy; Robert W Yeh; Ami B Bhatt
Journal:  Am J Cardiol       Date:  2016-06-27       Impact factor: 2.778

Review 6.  Postoperative residua and sequelae in adults with repaired tetralogy of Fallot.

Authors:  Munetaka Masuda
Journal:  Gen Thorac Cardiovasc Surg       Date:  2016-04-26

Review 7.  Pulmonic Valve Disease: Review of Pathology and Current Treatment Options.

Authors:  Mouhammad Fathallah; Richard A Krasuski
Journal:  Curr Cardiol Rep       Date:  2017-09-16       Impact factor: 2.931

Review 8.  Valvular heart disease in congenital heart disease: a narrative review.

Authors:  Joshua M Saef; Joanna Ghobrial
Journal:  Cardiovasc Diagn Ther       Date:  2021-06

9.  Pulmonic regurgitation and management challenges in the adult with tetralogy of fallot.

Authors:  Emily Ruckdeschel; Joseph D Kay
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-06

10.  Management of pulmonic regurgitation and right ventricular dysfunction in the adult with repaired tetralogy of fallot.

Authors:  Elisa Zaragoza-Macias; Karen K Stout
Journal:  Curr Treat Options Cardiovasc Med       Date:  2013-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.